Drug company settles over antibiotic claimBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6956.690 (Published 17 September 1994) Cite this as: BMJ 1994;309:690
- F B Charatan
The drug company Hoffmann-La Roche has agreed to pay the US Department of Health and Human Services (DHHS) $450 000 (pounds sterling300 000) to settle allegations of improper inducements to doctors and pharmacists to prescribe Rocephin (ceftriaxone), an antibiotic. An anti-kickback law prohibits the use of financial inducements to influence prescribing of products or services covered by Medicare and Medicaid, the federally funded health programmes.
The compromise settlement, which involved no admission of wrongdoing or liability by the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial